- Home
- IART vs ALVO Comparison
IART vs ALVO Comparison
Compare IART & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IART | ALVO |
|---|---|---|
| Founded | 1989 | 2013 |
| Country | United States | Luxembourg |
| Employees | N/A | 1460 |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | IART | ALVO |
|---|---|---|
| Price | $19.79 | $3.06 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 7 | 4 |
| Target Price | ★ $14.33 | $8.00 |
| AVG Volume (30 Days) | ★ 900.7K | 638.7K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $4.39 | $13.28 |
| Revenue Next Year | $3.40 | $18.63 |
| P/E Ratio | ★ N/A | $18.20 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.70 | $2.94 |
| 52 Week High | $20.26 | $9.94 |
Technical Indicators
Market Signals| Indicator | IART | ALVO |
|---|---|---|
| Relative Strength Index (RSI) | 63.53 | 35.84 |
| Support Level | $10.61 | $2.99 |
| Resistance Level | $20.26 | $3.94 |
| Average True Range (ATR) | 0.85 | 0.17 |
| MACD | -0.03 | -0.03 |
| Stochastic Oscillator | 85.23 | 0.98 |
Price Performance
Historical ComparisonAbout IART Integra LifeSciences Holdings Corporation
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.
About ALVO Alvotech
Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.